Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System"

Transcription

1 Cancer Research UK Clinical Trials/Research Unit Glasgow Quality System BEATSON WEST OF SCOTLAND CANCER CENTRE POLICY ON THE AWARENESS AND TRAINING OF STAFF MANAGING PATIENTS WITHIN THE CONTEXT OF A CLINICAL TRIAL To: All staff involved in managing patients on clinical trials within NHS Greater Glasgow and Clyde Health Board From: Clinical Trials Executive Committee Date: 08 Oct INTRODUCTION This policy document describes the levels of awareness or training in Good Clinical Practice (GCP) required for staff who manage patients on clinical trials conducted within NHS Greater Glasgow and Clyde Health Board (NHSGG&C) which have been approved by the Beatson West of Scotland Cancer Centre s Clinical Trials Executive Committee, based on their levels of involvement with trial patients. It also describes the level of training in the individual trial protocol that is required by these staff. 2. BACKGROUND All staff who manage patients in clinical trials must understand what awareness and/or training they require to carry out their role. There are two specific areas of awareness and training; the principles of GCP and the specific protocol(s) for the trial(s) on which they are working. The levels of awareness or training in each of these domains will depend upon the nature of the activities that they are delegated to perform. These levels are targeted at all individuals who may perform activities within clinical trials, e.g. radiographers, pharmacy staff, auxiliary staff, doctors, nurses. 3. LEVELS OF TRIAL INVOLVEMENT There are 3 levels of involvement for staff that manage trial patients within the BWoSCC: Level 1: Activity that is specified in the trial protocol, but which is conducted in exactly the same way as in routine care, e.g. recording of BP or ECG, and is conducted by an individual who would normally perform these activities during routine care. Level 2: Activity that is specified within the trial protocol and is unique to the trial, but which is within the normal remit of clinical responsibility for that member of staff. For example: o The administration of IV Investigational Medicinal Product (IMP) by a nurse trained in the administration of IV drugs. o Following an approved local dispensing procedure by pharmacy staff. In practice, there are few other examples. Level 3: Activity that is trial-specific and does not fall within the normal remit of clinical responsibility for the individual. Many activities performed by sub-investigators, research nurses and lead pharmacy contacts will fall into this category. Appendix II contains a list of examples of duties that would be performed at the above levels. 4. LEVELS OF AWARENESS/TRAINING Page 1 of 5 Version 2: 08 Oct 2015

2 For each activity level, there are corresponding degrees of training required in GCP and also trial-specific training: Level 1: 1. GCP training a brief GCP awareness document will be available to these staff members to consult in their area of activity, but no record will be kept as to whether or not this document has been received by individuals. 2. Trial-specific training no trial specific training is required, and these staff will not be listed on trial delegation logs or training logs. The responsibility for protocol compliance will lie with the member of the trial team who is instructing the individual to carry out this activity. The fact that the individual carrying out the activity does so as part of clinical job is considered sufficient evidence of training in the activity. The individual is not delegated to perform any activity within the trial that is not part of their everyday practice. Level 2: 1. GCP training abbreviated training will be provided to all relevant staff prior to undertaking trial activity. For Example: For nurses administering IV IMPs, this training will be part of the Chemotherapy Course, which is mandatory for all such staff. For other staff groups this will be organised by the appropriate line managers. This training will be documented and traceable, but will not necessarily be subject to planned or documented review unless there are significant changes in training requirements. 2. Trial-specific training this will depend on the staff group. For example: Nursing staff in this category will be made aware that the patient is on a clinical trial and will be informed as to whom to contact regarding that trial in the event of any concerns/aes. The mode of this communication will be dependent on the activity, e.g. for IMP administration this information will be on the chemotherapy prescription. Pharmacy staff in this category will undertake trial-specific training in relation to the locally approved dispensing procedures. This training will be carried out by a member of the lead pharmacy contacts team or another member of the pharmacy team, using a cascade system. This training will be documented on a training log that is stored in the pharmacy site file for the project. Level 2-only staff will not be required to sign a delegation log, but their signature next to the activity (e.g. on the chemotherapy prescription) will constitute such signature and will be filed in the source documentation but not the Investigator Site File (ISF). Level 3: 1. GCP training full GCP training must be undertaken by this group. This will be certificated, traceable and subject to renewal in accordance with an agreed renewal schedule (currently every 2 years). Please refer to the NHS Greater Glasgow and Clyde policy on GCP. 2. Trial-specific training The Principal Investigator (PI) is ultimately responsible for the training of this group in all delegated activities within the trial. Trial-specific training logs should be maintained in the ISF and all individuals undertaking these activities will be delegated to do so by the PI and this will be recorded in the delegation log in the ISF. 3. Any member of staff who prescribes IMPs must undergo full GCP training and be listed on delegation logs. There may be some exceptions to the activities which would typically be carried out under Level 3 training, whereby certain activities may be carried out by staff who have Level 2 training only, for example, non-medical prescribing. However, this practice will only be permitted on a case by case basis, following a risk assessment by the trial Sponsor and subsequent agreement between the R&D Governance Department and the trial Sponsor. 5. CTEC REVIEW and RISK ASSESSEMENT When a trial is reviewed by CTEC, the committee will identify the level of research resource to be provided for each trial. In some circumstances (e.g. clinical trials operating within the Clinical Research Unit), all trial activity will be conducted by individuals who are fully training in the protocol and GCP (e.g. Research nurses, doctors and lead pharmacy contacts). In such cases, it may be irrelevant what levels of activity are to be undertaken. When this is not the case, the CTEC Chair will conduct a risk assessment to identify any duties that fall within Level 2 (as documented in Section 3, above). Page 2 of 5 Version 2: 08 Oct 2015

3 6. RETENTION OF THE POLICY DOCUMENT This policy is accessed via the public area of the CRUK CTU website. Document control, distribution and retention are managed by the CRUK CTU Quality Assurance Manager, who is responsible for ensuring that the correct version is always available, the document is reviewed appropriately and timeously, and that superseded versions are archived appropriately. 7. REFERENCES NHS Greater Glasgow and Clyde Good Clinical Practice Policy 8. DOCUMENT HISTORY Version Approved Effective Reviewed Comments Version 1 11 Jan Jan Jul 2015 Additions to text in Sections 1 and 4. Addition of Section 6 Retention of the document. Version 2 Version 3 (Revision author: Michaela Rodger) Page 3 of 5 Version 2: 08 Oct 2015

4 Appendix I How do I know my patient is in a clinical study? The patient s case records will have a white sticker CLINICAL TRIAL PATIENT Please check inside notes for any instructions pertaining to the study CTU Contact for Study: CTC: Ext: Study No: Why do I need to know? For patient safety The Research Team for each study is responsible for the conduct of the study in this hospital. This includes reporting patient events which may be linked to their study participation to regulatory authorities. Please note All clinicians must report any Serious Adverse Events to the CTU immediately and fully document the event in case notes The Patient Information Sheet (PIS) and consent form will be filed in the case records along with the orange registration/randomisation sheet The Chemocare prescription identifies o the Beatson Study Number o which treatments are Investigational Medicinal Product (IMP) o the Research Team contact details What do I need to report? The Research Team need to know Any hospital admissions Any change to the patient treatment schedule Any abnormal observation parameters Any treatment compliance concerns Document in the case records and contact the Research Team Who should I ask? Every study has a Principal Investigator and a Clinical Trial Coordinator. Where possible there is also a Research Nurse assigned to the study. A general query? Contact the Clinical Trial Coordinator (CTC) A treatment related query? Contact the treatment prescribing medic or clinical trial pharmacist A concern about the study? The Principal Investigator, the local clinician responsible for the study Page 4 of 5 Version 2: 08 Oct 2015

5 Appendix II Examples of duties categorised as levels 1, 2 and 3 Level Duties Staff Group 1 Blood pressure Nursing 1 Pulse Nursing 1 Temperature Nursing 1 Respirations Nursing 1 Pulse Oximetry Nursing 1 Height Nursing 1 Weight Nursing 1 Urinalysis Nursing 1 Urine pregnancy test Nursing 1 ECG recording Nursing 1 Blood glucometer recording Nursing 1 Phlebotomy Nursing 1 Cannulation Nursing 1 Administration of IV drugs which are non IMP (NIMP) Nursing 1 Administration of IV chemotherapy which are NIMP Nursing 1 Administration of subcutaneous and intramuscular drugs which are NIMP Nursing 1 Administration or oral drugs which are NIMP Nursing 1 Administration of oral chemotherapy which are NIMP Nursing 2 Administration of trial drugs which are IMP Nursing 2 Receipt of IMP Pharmacy 2 Environmental Temperature Monitoring Pharmacy 2 Dispensing of NIMP Pharmacy 2 Dispensing of IMP for Phase II-IV trials Pharmacy 2 Accountability of IMP Pharmacy 2 Reconciliation of IMP Pharmacy 2 Destruction of IMP with sponsor approval Pharmacy 3 Any trial activity not covered by levels 1 and 2 Page 5 of 5 Version 2: 08 Oct 2015

Trial Management: Trial Master Files and Investigator Site Files

Trial Management: Trial Master Files and Investigator Site Files Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and

More information

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation

More information

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored

More information

Document Title: Study Data SOP (CRFs and Source Data)

Document Title: Study Data SOP (CRFs and Source Data) Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection Authorship Team: Jemma Hughes, Tina Morgan, for Joint SOP Group on Trial Processes (viz Leanne Quinn, Ian Russell, Anne

More information

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP) Reference Number: UHB 317 Version Number: 1 Date of Next Review: 7th July 2019 Previous Trust/LHB Reference Number: N/A TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

More information

JOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials.

JOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials. JOB DESCRIPTION JOB TITLE: Pharmacy Technician Haematology Clinical Trials PAY BAND: Agenda for change - Band 5 TERMS AND CONDITIONS DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PROFESSIONALLY RESPONSIBLE

More information

Investigator Site File Standard Operating Procedure (SOP)

Investigator Site File Standard Operating Procedure (SOP) Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse

More information

QUALITY ASSURANCE PROGRAM

QUALITY ASSURANCE PROGRAM QUALITY ASSURANCE PROGRAM Elaine Armstrong, MS Quality Assurance Manager PURPOSE Verify accuracy of submitted data Verify compliance with protocol and regulatory requirements Provide educational support

More information

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff Department Title of SOP Research & Development Case Report Form SOP SOP reference no: R&D GCP SOP 03 Authors: Current version number and date: J H Pacynko and J Illingworth Version 2, 01.02.18 Next review

More information

GCP INSPECTION CHECKLIST

GCP INSPECTION CHECKLIST (This list is not all inclusive; item may be added &/or deleted as per the Study/Site/Sponsor/Lab) I. General. Name and address of the clinical trial site Tel. No. & e- mail:. Date of Inspection. Inspection

More information

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator I2S2 TRAINING Good Clinical Practice tips Deirdre Thom Neonatal Nurse Coordinator Content Principal investigator (slides 3-5) Delegation and delegation log (slides 6-7) Informed consent (slides 8-15) Data

More information

Storage and Archiving of Research Documents SOP 6

Storage and Archiving of Research Documents SOP 6 Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager

More information

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG INFORMATION AND GUIDANCE SHEET FOR THE COMPLETION OF THE SITE SIGNATURE AND

More information

Clinical Study Risk Assessment

Clinical Study Risk Assessment Clinical Study Risk Assessment Clinical S.O.P. No.: 19 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited number by 1.0 New SOP Shona

More information

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)

More information

Standard Operating Procedure Research Governance

Standard Operating Procedure Research Governance Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision

More information

Adverse Event Reporting

Adverse Event Reporting Adverse Event Reporting Clinical S.O.P. No.: 15 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited Date edited number by 1.0 New SOP

More information

Safety Reporting in Clinical Research Policy Final Version 4.0

Safety Reporting in Clinical Research Policy Final Version 4.0 Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent

More information

CLINICAL TRIAL COORDINATOR Clinical Trials Unit Beatson West of Scotland Cancer Centre

CLINICAL TRIAL COORDINATOR Clinical Trials Unit Beatson West of Scotland Cancer Centre CLINICAL TRIAL COORDINATOR Clinical Trials Unit Beatson West of Scotland Cancer Centre Job Reference: 0000046503G Closing Date: 7 th April 2017 Dear applicant, Thank you for your interest in this post

More information

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED

More information

Prescribing Lactoferrin in the ELFIN Clinical trial

Prescribing Lactoferrin in the ELFIN Clinical trial Prescribing Lactoferrin in the ELFIN Clinical trial PAULA JENKINS RESEARCH NURSE NPEU Why Lactoferrin is deemed an Investigational Medicinal Product any substance or combination of substances presented

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa

More information

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK

More information

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Document Title: GCP Training for Research Staff. Document Number: SOP 005 Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Adverse Event Identification, Recording and Reporting in Clinical Trials of Investigational Medicinal SOP-RES-019 Version Number 2 Issue Date 08 th Dec

More information

Recommendations for the Retention of Pharmacy Records - prepared by the East of England NHS Senior Pharmacy Managers

Recommendations for the Retention of Pharmacy Records - prepared by the East of England NHS Senior Pharmacy Managers Recommendations for the Retention of Pharmacy s - prepared by the East of England NHS Senior Pharmacy Managers 2012-13 RECORDS THAT PERTAIN TO ALL PHARMACY SETTINGS Clinical governance Competency/training

More information

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION SOP: NN SS 401 Version No.: 2.0 Effective Date: 21Oct2016 SITE SELECTION AND QUALIFICATION Supercedes Document:

More information

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)

More information

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

This Agreement dated DD/MM/YYYY (the Effective Date ) is between Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7

More information

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:

More information

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS European Medicines Agency Inspections London, 23 July 2008 EMEA/INS/GCP/197215/2005 Procedure no.: INS/GCP/3/V ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS GCP

More information

Effective Date: 11/09 Policy Chronicle:

Effective Date: 11/09 Policy Chronicle: Title: Investigational Drug Service Functions Policy Type: Clinical Operations Replaces (supersedes): Title: N/A Policy Chronicle: Date Original Version of Policy was Effective: 09/06 Reviewer Signature:

More information

Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by

Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by Contract Research Organisations (CRO mcia, 2011 version)

More information

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Assessment criteria The learner can:

Assessment criteria The learner can: HSC 3052: Undertake measurements Unit reference R/601/8662 Level 3 Credit value 3 GLH 23 Unit aim This unit is aimed at health & social care staff involved in the taking and ing of measurements as part

More information

Prescribing and Administration of Medication Procedure

Prescribing and Administration of Medication Procedure Prescribing and Administration of Medication Procedure Version: 3.3 Bodies consulted: - Approved by: PASC Date Approved: 1.4.16 Lead Manager Lead Director: Head of Child and Adolescent psychiatry Medical

More information

Document Title: Research Database Application (ReDA) Document Number: 043

Document Title: Research Database Application (ReDA) Document Number: 043 Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of

More information

Clinical Trial Readiness Checklist October 2014

Clinical Trial Readiness Checklist October 2014 The clinical trial readiness checklist is a tool which can help new and experienced researchers prepare for upcoming clinical studies. It is designed to be a quick reference to ensure that you have the

More information

ORAL ANTI-CANCER THERAPY POLICY

ORAL ANTI-CANCER THERAPY POLICY ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive

More information

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures

More information

Study Monitoring Plan Template

Study Monitoring Plan Template Study Monitoring Plan Template Sponsor Reference Number: Study Title: Principal Investigator: Study Centre: The Sponsor risk assessment form and the trial risk based monitoring strategy appendices 2 &

More information

Systemic Anti-Cancer Therapy Delivery. June 2017 National External Review

Systemic Anti-Cancer Therapy Delivery. June 2017 National External Review Systemic Anti-Cancer Therapy Delivery June 2017 National External Review Healthcare Improvement Scotland is committed to equality. We have assessed the review process for likely impact on equality protected

More information

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially

More information

Document Title: Research Database Application (ReDA) Document Number: 043

Document Title: Research Database Application (ReDA) Document Number: 043 Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1.1 Ratified by: Committee Date ratified: 23 February 2017 Name of originator/author: Rachel Fay Directorate: Medical

More information

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company

More information

Central Alerting System (CAS) Policy

Central Alerting System (CAS) Policy Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray

More information

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion. THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines

More information

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

Joint Statement on the Application of Good Clinical Practice to Training for Researchers Joint Statement on the Application of Good Clinical Practice to Training for Researchers HRA, MHRA, Devolved Administrations for Northern Ireland, Scotland and Wales v1.1 12/10/17 Summary This joint statement

More information

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 1 2 31 January 2017 EMA/430909/2016 3 4 5 Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or Draft Adopted by GCP Inspectors Working Group (GCP IWG) 30 January 2017 Adopted

More information

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements 6.00.00 PHARMACEUTICAL CARE, DRUG THERAPY MANAGEMENT AND PRACTICE BY PROTOCOL. 6.00.10 Definitions. a. "Pharmaceutical care" means the provision of drug therapy and other pharmaceutical patient care services

More information

Research Adverse Event and Safety Reporting Procedures Outcome Statement: Title:

Research Adverse Event and Safety Reporting Procedures Outcome Statement: Title: Title: Research Adverse Event and Safety Reporting Procedures Outcome Statement: Research Teams will be able to correctly identify and report Adverse Events and complete Annual Safety Reports for research

More information

Executive Director of Nursing and Chief Operating Officer

Executive Director of Nursing and Chief Operating Officer Document Title Arrangements for Managing Patients Mental and Physical Health Needs across NTW and the Acute Hospital Trusts Reference Number Lead Officer Author(s) (name and designation) Ratified by NTW(C)15

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM 003 SOP category: Trial Management Version number: 03 Version date:

More information

Adverse Event Reporting

Adverse Event Reporting Adverse Event Reporting The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.thh.nhs.uk/departments/research/research.htm

More information

Babylon Healthcare Services

Babylon Healthcare Services Babylon Healthcare Services Limited Babylon Healthcare Services Ltd. Inspection report 60 Sloane Avenue London SW3 3DD Tel: 0207 1000762 Website: www.babylonhealth.com Date of inspection visit: 4 July

More information

Document Title: Version Control of Study Documents. Document Number: 023

Document Title: Version Control of Study Documents. Document Number: 023 Document Title: Version Control of Study Documents Document Number: 023 Version: 1.1 Ratified by: Committee Date ratified: 03 OCT 2017 Name of originator/author: Directorate: Department: Name of responsible

More information

STANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES

STANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES STANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES Issue History Issue Version Purpose of Issue/Description of Change

More information

NHS Greater Glasgow & Clyde Non-medical Prescribing Policy & Procedure

NHS Greater Glasgow & Clyde Non-medical Prescribing Policy & Procedure Page 1 of 24 Page 1 of 24 NHS Greater Glasgow & Clyde Non-medical Prescribing Policy & Procedure Page 1 of 24 DOCUMENT PRODUCED BY: Jane Camp Page 1 of 24 1. Introduction 3 1.1. Aims of the NMP Policy

More information

Using Practitioner Supply Orders and Standing Orders in the Rheumatic Fever Prevention Programme. Guidance for sore throat management services

Using Practitioner Supply Orders and Standing Orders in the Rheumatic Fever Prevention Programme. Guidance for sore throat management services Using Practitioner Supply Orders and Standing Orders in the Rheumatic Fever Prevention Programme Guidance for sore throat management services February 2015 Citation: Ministry of Health. 2015. Using Practitioner

More information

Corporate. Research Governance Policy. Document Control Summary

Corporate. Research Governance Policy. Document Control Summary Corporate Research Governance Policy Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date:

More information

Appendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH

Appendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH Appendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH All prescribers and their managers/professional leads should ensure

More information

Qualifications Support Pack 03. Making Claims & Results

Qualifications Support Pack 03. Making Claims & Results Qualifications Support Pack 03 Making Claims & Results August 2016 1 CONTENTS Contacting Prince s Trust Qualifications... 3 QUALIFICATION CLAIMS... 4 Centre Approval... 4 Registering Learners... 4 Making

More information

Unlicensed Medicines Policy

Unlicensed Medicines Policy Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention

More information

RESEARCH GOVERNANCE POLICY

RESEARCH GOVERNANCE POLICY RESEARCH GOVERNANCE POLICY DOCUMENT CONTROL: Version: V6 Ratified by: Performance and Assurance Group Date ratified: 12 November 2015 Name of originator/author: Assistant Director of Research Name of responsible

More information

Standards for side effect monitoring

Standards for side effect monitoring Standards for side effect monitoring What you can expect All medicines can cause unwanted side-effects. It is our responsibility to monitor your response to medication and any negative effects. We have

More information

GCP Training for Research Staff. Document Number: 005

GCP Training for Research Staff. Document Number: 005 GCP Training for Research Staff Document Number: 005 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case

POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk

More information

Systemic anti-cancer therapy Care Pathway

Systemic anti-cancer therapy Care Pathway Network Guidance Document Status: Expiry Date: Version Number: Publication Date: Final July 2013 V2 July 2011 Page 1 of 9 Contents Contents... 2 STANDARDS FOR PREPARATION AND PHARMACY... 3 1.1 Facilities

More information

Ingham Institute for Applied Medical Research Clinical Trials Coordinator POSITION DESCRIPTION

Ingham Institute for Applied Medical Research Clinical Trials Coordinator POSITION DESCRIPTION Ingham Institute for Applied Medical Research Clinical Trials Coordinator POSITION DESCRIPTION Research Group: Status: Hours: Salary: Reports to: Haematology Clinical Trials Full-time for one (1) year.

More information

Mastering Clinical Research April 19, :30 am

Mastering Clinical Research April 19, :30 am Mastering Clinical Research April 19, 2017 7:30 am New Question and Answer Response System Log In Directions Use the following link to access pre and post test questions: http://www.socrative.com/ Click

More information

Medicines Governance Service to Care Homes (Care Home Service)

Medicines Governance Service to Care Homes (Care Home Service) Medicines Governance Service to Care Homes (Care Home Service) Locally Enhanced Service Authors: Ruth Buchan, Senior Pharmacist Medicines Management 4th Floor F Mill Dean Clough Halifax HX3 5AX Tel-01422

More information

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix

More information

ADVANCED SERVICES (Pharmacy Contractors)

ADVANCED SERVICES (Pharmacy Contractors) ADVANCED SERVICES (Pharmacy Contractors) MEDICINE USE REVIEWS 1 Background 1.1 The South (South West) Area Team for Devon Cornwall & Isles of Scilly (DCIoS) supports the provision of the advanced service

More information

Version 4 January 18, Principal Investigator: James F. Marion, M.D. The Mount Sinai School of Medicine

Version 4 January 18, Principal Investigator: James F. Marion, M.D. The Mount Sinai School of Medicine Guidelines for Completing Case Report Forms For A Six-Week Randomized Double-Blind, Controlled Trial of High Dose Asacol (6.0 g/day) Versus Low Dose Asacol (2.4 or 3.6 g/day) for the Treatment of Mild

More information

Patient Group Direction (PGD) template

Patient Group Direction (PGD) template Patient Group Direction (PGD) template Initial supply of doxycycline 100mg capsules to adults and children aged eight (8) years and over exposed to a suspected biological agent Version no: 2014/2 Valid

More information

Guidance for registered pharmacies preparing unlicensed medicines

Guidance for registered pharmacies preparing unlicensed medicines Guidance for registered pharmacies preparing unlicensed medicines May 2014 The text of this document (but not the logo and branding) may be reproduced free of charge in any format or medium, as long as

More information

managing or activities.

managing or activities. STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This

More information

Research & Development Quality Manual

Research & Development Quality Manual Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager Version: 3 Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School Document History

More information

NCCP Guidance on the Retention and Disposal of Systemic Anti-Cancer Therapy (SACT) prescriptions and compounding worksheets.

NCCP Guidance on the Retention and Disposal of Systemic Anti-Cancer Therapy (SACT) prescriptions and compounding worksheets. NCCP Guidance on the Retention and Disposal of Systemic Anti-Cancer Therapy (SACT) prescriptions and compounding worksheets. Version Date Amendment Approved By 1 11/01/2017 Version 1 NCCP following consultation

More information

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation

More information

NHSLA Risk Management Standards

NHSLA Risk Management Standards NHSLA Risk Management Standards 2012-13 for NHS Trusts providing Acute Services Brighton and Sussex University Hospitals NHS Trust Level 1 October 2012 Contents Executive Summary... 3 Assessment Outcome...

More information

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist Policy on Pharmacological Therapies Practice Guidance Note The use of Oral Anti-Cancer Medicines and Oral Methotrexate within - V03 V03 - Issued Issue 1 Dec 15 Planned review December 2018 PPT-PGN 09 Part

More information

Registrant Survey 2013 initial analysis

Registrant Survey 2013 initial analysis Registrant Survey 2013 initial analysis April 2014 Registrant Survey 2013 initial analysis Background and introduction In autumn 2013 the GPhC commissioned NatCen Social Research to carry out a survey

More information

DATA COLLECTION SHEET (NURSES)

DATA COLLECTION SHEET (NURSES) ANNEXURE A DATA COLLECTION SHEET (NURSES) 1.0 NURSES DEMOGRAPHIC DATA 1.1 Research Code 1.2 Professional Qualification 1.3 Shift Day Night 1.3 Years of Nursing Experience Years Months 1.4 Period Working

More information

Section 9. Study Product Considerations for Non- Pharmacy Staff

Section 9. Study Product Considerations for Non- Pharmacy Staff Section 9. Study Product Considerations for Non- Pharmacy Staff Table of Contents 9.1 Dispensing Study Product 9.1.1 Chain of Custody 9.1.2 Initial Vaginal Ring Dispensing(s)- Prescription Overview 9.2

More information

NHS and LA Reforms Factsheet 5

NHS and LA Reforms Factsheet 5 NHS and LA Reforms Factsheet 5 Supply of medicines for public health commissioned services a factsheet for local authorities 1. Introduction As of April 2013, local authorities have responsibility for

More information

Scotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists

Scotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists Scotia College of Pharmacists Standards of Practice Practice Directive Prescribing of Drugs by Pharmacists September 2014 ACKNOWLEDGEMENTS This Practice Directives document has been developed by the Prince

More information

STAFF UNIFORM AND DRESS POLICY

STAFF UNIFORM AND DRESS POLICY STAFF UNIFORM AND DRESS POLICY Lead Manager: Responsible Director: Approved by: Uniform Short Life Working Group Director, Human Resources Date approved: 30 March 2010 Date for Review: March 2013 Replaces

More information

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC Documenting the Story of a Clinical Trial: Concept to CAPA Lori T. Gilmartin Gilmartin Consulting LLC The regulations represent the floor while ethical thinking is the sky. Dr. Thomas Moore Boston University

More information

EMERGENCY CARE DISCHARGE SUMMARY

EMERGENCY CARE DISCHARGE SUMMARY EMERGENCY CARE DISCHARGE SUMMARY IMPLEMENTATION GUIDANCE JUNE 2017 Guidance for implementation This section sets out issues identified during the project which relate to implementation of the headings.

More information

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the

More information

Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business

Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business to facilitate compliance with Regulation 12 of the Regulation of Retail Pharmacy Businesses

More information

Annual Report

Annual Report Equality and Diversity Steering Group Annual Report 2012-2013 April 2013 1 Contents Page No Introduction 3 Equality Act 2010 3 NHS Lanarkshire s Equality and Diversity Reporting Structure Equality and

More information

Standard 1: Governance for Safety and Quality in Health Service Organisations

Standard 1: Governance for Safety and Quality in Health Service Organisations Standard 1: Governance for Safety and Quality in Health Service Organisations riterion: Governance and quality improvement system There are integrated systems of governance to actively manage patient safety

More information

SENIOR RESEARCH NURSE - CLINICAL RESEARCH FACILITY Queen Elizabeth University Hospital. Job Reference: N Closing Date: 30 March 2018

SENIOR RESEARCH NURSE - CLINICAL RESEARCH FACILITY Queen Elizabeth University Hospital. Job Reference: N Closing Date: 30 March 2018 SENIOR RESEARCH NURSE - CLINICAL RESEARCH FACILITY Queen Elizabeth University Hospital Job Reference: 0000050999N Closing Date: 30 March 2018 Dear applicant, Thank you for your interest in this post and

More information

Standards of proficiency for nursing associates

Standards of proficiency for nursing associates Standards of proficiency for nursing associates DRAFT April 2018 www.nmc.org.uk Contents Introduction 3 Standards of proficiency for nursing associates 5 Platform 1: Being an accountable professional 5

More information

abcdefghijklmnopqrstu

abcdefghijklmnopqrstu Directorate of Chief Medical Officer, Public Health and Sport abcdefghijklmnopqrstu T: 0131-244 2655 F: 0131-244 2285 E: craig.gilbert@scotland.gsi.gov.uk Dear Colleague ACCREDITATION SCHEME FOR THE COLLECTION

More information

Medicines Reconciliation: Standard Operating Procedure

Medicines Reconciliation: Standard Operating Procedure Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation

More information